Leaps by the numbers
New investments and follow-on investments 2023
1.9+ Billion USD
Total amount invested in Leaps portfolio 2015 - 2023
# of portfolio companies 2015 - 2023
Leaps is the strategic impact investment unit of Bayer. By accelerating transformative biotechnologies, we aim to shift key paradigms in life science, changing the world for better.
In health, we pursue breakthroughs that could set new standards in medical care, moving from treating symptoms to curing or preventing diseases. In agriculture, we drive innovations that could nourish a growing population while restoring the planet.
Our ten Leaps are at the core of our investment approach. They reflect our ambition to tackle the biggest challenges, with consideration for how Bayer’s 150 years of history and expertise can most make a difference.
01 / Cure genetic diseases
Stopping genetic diseases before they progress could prevent chronic suffering and give each of us the chance to live a full and healthy life.
02 / Provide sustainable organ and tissue replacement
Cell and gene therapies hold tremendous promise to restore health, reverse the course of degenerative diseases and prevent organ failure.
03 / Reduce environmental impact of agriculture
From carbon sequestration to reducing land and water usage, innovation has the power to transform modern agriculture.
04 / Prevent and cure cancer
Biotechnology that leverages the immune system and other emerging platforms could make huge strides in the fight against cancer.
05 / Protect brain and mind
Neurodevelopmental and neurodegenerative disease along with mental health disorders represent a massive and growing unmet need with no simple solutions available.
06 / Reverse autoimmune diseases and chronic inflammation
Systematically addressing autoimmune diseases and chronic inflammation could enable lives free of pain, disease management, and life-threatening conditions.
07 / Provide next generation healthy crops
The Green Revolution lifted millions out of starvation, yet new approaches are needed to provide comprehensive nutrition at a global scale.
08 / Develop sustainable protein supply
Nourishing a global population will require new approaches to sustain both a healthy planet and healthy people.
09 / Prevent crop and food loss
A pandemic, climate volatility, and an increasingly long and complex supply chain expose the fragility of our global food system and the need for resilience.
10 / Transform health with data
From wearable devices to artificial intelligence to protein modeling, digital technology is sparking a revolution in medicine.
Growing knowledge through collaboration
Leaps by Bayer supports early-stage companies and forms new ventures. Significant and sustained investment maximizes their probability of success and enables them to focus on the long-term delivery of their disruptive technology, rather than short-term and lower impact results.
Our portfolio companies remain autonomous with respect to decision making. We support them through what we call “active incubation”. Experienced team members actively engage in the young companies’ development by providing resources and helping them to steer the initial strategic direction.
Return for humanity
How much wellbeing for humanity could we create by e.g., resolving Parkinson’s disease? Or ensuring crop shortages are less severe?
We seek to predict and measure our impact investment approach by developing a new metric of success beyond ROI.
Together with the Happiness Research Institute, we introduced Wellbeing Adjusted Life Years (WALY), a metric determining the impact events have on wellbeing, which also allows to predict how much good for humanity we could generate by addressing disease and solving global issues.
Ethical questions need a platform
Biotech breakthroughs raise important ethical questions that can’t be answered by scientists and investors alone. It is our responsibility to engage society in critical discussions.